featured
Effects of Acarbose on Cardiovascular and Diabetes Outcomes in Patients With Coronary Heart Disease and Impaired Glucose Tolerance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Acarbose on Cardiovascular and Diabetes Outcomes in Patients With Coronary Heart Disease and Impaired Glucose Tolerance (ACE): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet Diabetes Endocrinol 2017 Sep 12;[EPub Ahead of Print], RR Holman, RL Coleman, JCN Chan, JL Chiasson, H Feng, J Ge, HC Gerstein, R Gray, Y Huo, Z Lang, JJ McMurray, L Rydén, S Schröder, Y Sun, MJ Theodorakis, M Tendera, L Tucker, J Tuomilehto, Y Wei, W Yang, D Wang, D Hu, C PanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.